Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEHZQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,033
Award facts
- Contract value 100% obligated
- $17,032.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $17,032.94 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on December 16, 2025, with an ultimate completion date of December 17, 2025, was awarded without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products and medical consumables to the Department of Defense, including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and over-the-counter drugs.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, awarded on November 13, 2025, with a $499,999,999 ceiling value and completion date of December 31, 2036. The PPV-G GEN V represents part of a broader $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors supplying pharmaceutical products to military healthcare facilities worldwide. The IDC structure authorizes DLA to issue firm fixed-price delivery orders for the diverse and specialized pharmaceutical requirements of the federal military medical system, positioning DMS Pharmaceutical Group as a critical pharmaceutical supplier supporting Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DU26FEHZQ?
SPE2DU26FEHZQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DU26FEHZQ worth?
The government has obligated $17,033 on SPE2DU26FEHZQ.
Is contract SPE2DU26FEHZQ an order under another contract?
Yes. SPE2DU26FEHZQ is a delivery order under SPE2DU25D9415, an indefinite delivery contract.
Was contract SPE2DU26FEHZQ competed?
The extent of competition for SPE2DU26FEHZQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award